Search Results

There are 2522 results for: content related to: A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years

  1. Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 79, Issue 5, May 2015, Pages: 744–755, Malcolm Boyce, Sally Dowen, Gillian Turnbull, Frans van den Berg, Chun-Mei Zhao, Duan Chen and James Black

    Article first published online : 22 APR 2015, DOI: 10.1111/bcp.12534

  2. You have free access to this content
    An open-label, parallel, multiple-dose study comparing the pharmacokinetics and gastric acid suppression of rabeprazole extended-release with esomeprazole 40 mg and rabeprazole delayed-release 20 mg in healthy volunteers

    Alimentary Pharmacology & Therapeutics

    Volume 33, Issue 7, April 2011, Pages: 845–854, G. Morelli, H. Chen, G. Rossiter, B. Rege and Y. Lu

    Article first published online : 28 JAN 2011, DOI: 10.1111/j.1365-2036.2011.04580.x

  3. You have free access to this content
    Rabeprazole-based therapies in Helicobacter pylori eradication

    Alimentary Pharmacology & Therapeutics

    Volume 17, Issue 6, March 2003, Pages: 751–764, J. P. Gisbert, S. Khorrami, X. Calvet and J. M. Pajares

    Article first published online : 17 MAR 2003, DOI: 10.1046/j.1365-2036.2003.01450.x

  4. You have free access to this content
    Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24-h intragastric acidity and oesophageal acid exposure: a randomized study in gastro-oesophageal reflux disease patients with a history of nocturnal heartburn

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 9, May 2010, Pages: 991–1000, P. MINER, B. DELEMOS, J. XIANG, J. LOCOCO and J. IENI

    Article first published online : 2 FEB 2010, DOI: 10.1111/j.1365-2036.2010.04255.x

  5. Helicobacter pylori treatment in children: Defining a dose for rabeprazole as a part of a triple therapy regimen

    The Journal of Clinical Pharmacology

    Volume 55, Issue 5, May 2015, Pages: 592–600, Holly Kimko, An Thyssen, Diane R. Mould, Erik Mannaert and William R. Treem

    Article first published online : 4 FEB 2015, DOI: 10.1002/jcph.457

  6. The chiral bioconversion and preclinical pharmacokinetic analysis of (R)-(+)-rabeprazole in beagle dogs by HPLC and HPLC-MS/MS

    Biomedical Chromatography

    Volume 27, Issue 11, November 2013, Pages: 1380–1386, Yan-hui Gao, Jia-xing Xu, Zhong-xue Su, Li Song and Hong-xiang Lou

    Article first published online : 22 MAY 2013, DOI: 10.1002/bmc.2932

  7. You have full text access to this OnlineOpen article
    Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects - a randomised open-label cross-over study

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 6, September 2015, Pages: 719–730, Y. Sakurai, Y. Mori, H. Okamoto, A. Nishimura, E. Komura, T. Araki and M. Shiramoto

    Article first published online : 21 JUL 2015, DOI: 10.1111/apt.13325

  8. You have free access to this content
    Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status

    British Journal of Clinical Pharmacology

    Volume 61, Issue 3, March 2006, Pages: 309–314, Tsukasa Uno, Mikiko Shimizu, Norio Yasui-Furukori, Kazunobu Sugawara and Tomonori Tateishi

    Article first published online : 1 DEC 2005, DOI: 10.1111/j.1365-2125.2005.02556.x

  9. Pharmacokinetics of rabeprazole granules versus tablets, and the effect of food on the pharmacokinetics of rabeprazole granules in healthy adults—cross-study comparison

    Clinical Pharmacology in Drug Development

    Volume 3, Issue 5, September/October 2014, Pages: 406–416, An Thyssen, Bhavna Solanki, Martha Gonzalez, Gerhard Leitz, William Treem and Erik Mannaert

    Article first published online : 23 MAY 2014, DOI: 10.1002/cpdd.118

  10. You have free access to this content
    Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States

    Alimentary Pharmacology & Therapeutics

    Volume 22, Issue 3, August 2005, Pages: 193–202, A. CAOS, J. BREITER, C. PERDOMO and J. BARTH

    Article first published online : 29 JUL 2005, DOI: 10.1111/j.1365-2036.2005.02555.x

  11. Review article: comparative pharmacodynamic review of rabeprazole – focus on day 1 data

    Alimentary Pharmacology & Therapeutics Symposium Series

    Volume 2, Issue 2, July 2006, Pages: 315–326, M. ROBINSON and J. BARONE

    Article first published online : 26 JUN 2006, DOI: 10.1111/j.1746-6342.2006.00062.x

  12. Simultaneous determination of rabeprazole and its two active metabolites in human urine by liquid chromatography with tandem mass spectrometry and its application in a urinary excretion study

    Journal of Separation Science

    Volume 37, Issue 15, August 2014, Pages: 1951–1956, Ernest Simpemba, Ruijuan Liu, Chenglong Sun, Janvier Engelbert Agbokponto and Li Ding

    Article first published online : 30 JUN 2014, DOI: 10.1002/jssc.201400162

  13. You have free access to this content
    A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 6, June 2000, Pages: 691–699, Williams, Blanshard, Millson, Sercombe and Pounder

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00772.x

  14. Randomised clinical trial: prevention of recurrence of peptic ulcers by rabeprazole in patients taking low-dose aspirin

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 7, October 2014, Pages: 780–795, R. Iwakiri, K. Higuchi, M. Kato, M. Fujishiro, Y. Kinoshita, T. Watanabe, T. Takeuchi, M. Yamauchi, M. Sanomura, H. Nakagawa, N. Sugisaki, Y. Okada, H. Ogawa, T. Arakawa and K. Fujimoto

    Article first published online : 6 AUG 2014, DOI: 10.1111/apt.12907

  15. You have free access to this content
    The effects of oral rabeprazole on endocrine and gastric secretory function in healthy volunteers

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 9, September 1999, Pages: 1195–1203, Dammann, Burkhardt and Wolf

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00545.x

  16. You have free access to this content
    Clinical trial: maintenance intermittent therapy with rabeprazole 20 mg in patients with symptomatic gastro-oesophageal reflux disease – a double-blind, placebo-controlled, randomized study

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 9, May 2010, Pages: 950–960, R. FASS, B. DELEMOS, L. NAZARENO, R. KAO, J. XIANG and Y. LU

    Article first published online : 2 FEB 2010, DOI: 10.1111/j.1365-2036.2010.04254.x

  17. You have free access to this content
    Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes

    British Journal of Clinical Pharmacology

    Volume 61, Issue 3, March 2006, Pages: 315–320, Masatomo Miura, Hideaki Kagaya, Hitoshi Tada, Tsukasa Uno, Norio Yasui-Furukori, Tomonori Tateishi and Toshio Suzuki

    Article first published online : 20 DEC 2005, DOI: 10.1111/j.1365-2125.2005.02566.x

  18. Time-Dependent Amplified Pharmacokinetic and Pharmacodynamic Responses of Rabeprazole in Cytochrome P450 2C19 Poor Metabolizers

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 23, Issue 6, June 2003, Pages: 711–719, Chun-Jung Lin, Jyh-Chin Yang, Yow-Shieng Uang, Herng-Der Chern and Teh-Hong Wang

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.23.6.711.32177

  19. You have free access to this content
    Helicobacter pylori infection influences nocturnal gastric acid breakthrough

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 8, August 2000, Pages: 1049–1056, T. Katsube, K. Adachi, A. Kawamura, K. Amano, Y. Uchida, M. Watanabe and Y. Kinoshita

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00799.x

  20. You have free access to this content
    Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24-h intragastric pH and serum gastrin in healthy subjects

    Alimentary Pharmacology & Therapeutics

    Volume 16, Issue 7, July 2002, Pages: 1301–1307, S. Warrington, K. Baisley, M. Boyce, B. Tejura, A. Morocutti and N. Miller

    Article first published online : 25 JUL 2002, DOI: 10.1046/j.1365-2036.2002.01292.x